Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 5, 2008, Pages 762-771

  Budde, Ulrich ^a,r   Schneppenheim, R ^b   Eikenboom, J ^c   Goodeve, A ^d   Will, K ^a   Drewke, E ^a   Castaman, G ^e   Rodeghiero, F ^e   Federici, A B ^f   Batlle, J ^g   Perez A ^g   Meyer, D ^h   Mazurier, C ⁱ   Goudemand, J ^j   Ingerslev, J ^k   Habart, D ^l   Vorlova, Z ^m   Holmberg, L ⁿ   Lethagen, S ⁿ   Pasi, J ^o,p   Hill, F ^q   Peake, I ^d   more..

^a Coagulation Laboratory   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e SAN BORTOLO HOSPITAL   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g Hospital Teresa Herrera   (Spain)

^h INSERM   (France)

ⁱ Laboratoire Francais du Fractionnement et des Biotechnologies   (France)

^j UNIV LILLE   (France)

^k AARHUS UNIVERSITY HOSPITAL   (Denmark)

^l SCRIPPS RESEARCH INSTITUTE   (United States)

^m INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

ⁿ LUND UNIVERSITY   (Sweden)

^o Mental Health Center Glostrup   (Denmark)

^p QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^q BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^r Aesculabor Hamburg GmbH   (Germany)

more..

Author keywords

Multimer analysis; Mutation; Type 1; von Willebrand disease; von Willebrand factor

Indexed keywords

MOLECULAR MARKER; POLYMER; RISTOCETIN; VON WILLEBRAND FACTOR;

AMINO ACID SUBSTITUTION; ANAMNESIS; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING PARAMETERS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELETION MUTANT; DIAGNOSTIC ERROR; DISEASE CLASSIFICATION; DISEASE MARKER; EUROPE; FRAMESHIFT MUTATION; GENETIC ANALYSIS; GENETIC TRAIT; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MULTICENTER STUDY; MUTATIONAL ANALYSIS; OPTICAL RESOLUTION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; VON WILLEBRAND DISEASE;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIMERIZATION; EPIDEMIOLOGY, MOLECULAR; EUROPE; FAMILY HEALTH; GENOTYPE; HUMANS; MUTATION; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 42149120672     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.02945.x     Document Type: Article

References (21)

1. Rodeghiero F, Castaman GC, Dini E. Epidemiological investigationof the prevalence of von Willebrand's disease. Blood 1987; 69: 454-9.
2. Werner EJ, Emmett H, Tucker E, Giroux D, Schultz J, Abshire T. Prevalence of von Willebrand disease in children. A multiethnic study. J Pediatr 1993; 123: 93-8.
3. Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998; 67: 395-424.
4. Sadler JE. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1994; 71: 520-5.
5. Sadler JE, Budde U, Eikenboom JCJ, Favaloro EJ, Hill FG, Holmberg L, Ingerslev J, Lee CA, Lillicrap D, Mannucci PM, Mazurier C, Meyer D, Nichols WL, Nishino M, Peake IR, Rodeghiero F, Schneppenheim R, Ruggeri ZM, Srivastava A, Montgomery RR, et al. Working Party on von Willebrand Disease Classification. Update on the pathophysiology and classification of von Willebrand disease: A report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006; 4: 2103-14.
6. Sadler JE, Rodeghiero F. Provisional criteria for the diagnosis of VWD type 1. J Thromb Haemost 2005; 3: 775-7.
7. Budde U, Pieconka A, Will K, Schneppenheim R. Laboratory testing for von Willebrand disease: Contribution of multimer analysis to diagnosis and classification. Semin Thromb Hemost 2006; 32: 514-21.
8. Goodeve A, Eikenboom J, Castaman G, Rodeghiero F, Federici AB, Battle J, Meyer D, Mazurier C, Goudemand J, Schneppenheim R, Budde U, Ingerslev J, Habart D, Vorlova Z, Holmberg L, Lethagen S, Pasi J, Hill F, Hashemi Soteh M, Baronciani L et.al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD). Blood 2007; 109: 112-21.
9. Tosetto A, Rodeghiero F, Castaman G, Goodeve A, Federici AB, Battle J, Meyer D, Fressinaud E, Mazurier C, Goudemand J, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, Hill F et.al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: Results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2006; 4: 766-73.
10. Tosetto A, Rodeghiero F, Castaman G, Bernardi M, Bertoncello K, Goodeve A, Federici AB, Battle J, Meyer D, Mazurier C, Goudemand J, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J et.al. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: Results from a multicenter European study (MCMDM-1VWD). J Thromb Haemost 2007; 5: 715-21.
11. Eikenboom J, van Marion V, Putter H, Goodeve A, Rodeghiero F, Castaman G, Federici AB, Battle J, Meyer D, Mazurier C, Goudemand J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, Hill F et.al. Linkage Analysis in Families Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD). J Thromb Haemost 2006; 4: 774-82.
12. Ruggeri ZM, Zimmerman TS. Variant von Willebrand's disease. Characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets. J Clin Invest 1980; 65: 1318-25.
13. Schneppenheim R, Plendl H, Budde U. Luminography - an alternative assay for detection of von Willebrand factor multimers. Thromb Haemost 1988; 60: 133-6.
14. Zimmerman TS, Dent JA, Ruggeri ZM, Nannini LH. Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID and IIE). J Clin Invest 1986; 77: 947-51.
15. Hoyer LW, Rizza CR, Tuddenham EG, Carta CA, Armitage H, Rotblat F. von Willebrand factor multimer patterns in von Willebrand's disease. Br J Haematol 1983; 55: 493-507.
16. Castaman G, Missiglia E, Federici AB, Schneppenheim R, Rodeghiero F. An additional unique candidate mutation (G2470A; M740I) in the original families with von Willebrand disease type 2M Vicenza and the G3864A (R1205H) mutation. Thromb Haemost 2000; 84: 8350-1.
17. Schneppenheim R, Federici AB, Budde U, Castaman G, Drewke E, Krey S, Mannucci PM, Riesen G, Rodeghiero F, Zieger B, Zimmermann R. Von Willebrand disease type 2M "Vicenza" in Italian and German patients: Identification of the first candidate mutation(G3864A; R1205H) in 8 families. Thromb Haemost 2000; 83: 136-40.
18. Eikenboom JCJ, Matushita T, Reitsma PH, Tuley EA, Castaman G, Briet E, Sadler JE. Dominant type I von Willebrand disease caused by mutated Cysteine residues in the D3 domain of von Willebrand factor. Blood 1996; 88: 2433-41.
19. Casana P, Martinez F, Espinos C, Haya S, Lorenzo JI, Aznar JA. Search for mutations in a segment of exon 28 of the human von Willebrand factor gene: New mutations, R1315C and R1341W, associated with type 2M and 2B variants. Am J Hematol 1998; 59: 57-63.
20. Ribba AS, Hilbert L, Lavergne J-M, Fressinaud E, Boyer-Neumann C, Temisien C, Juhan-Vague I, Goudemand J, Girma J-P, Mazurier C, Meyer D. The arginine-522-cysteine (R1315C) mutation within the A1 loop of von Willebrand factor induces abnormal folding with a loss of function resulting in type 2A-like phenotype of von Willebrand disease: Study of 10 patients and mutated recombinant von Willebrand factor. Blood 2001; 97: 952-9.
21. Federici AB. Diagnosis of von Willebrand disease. Haemophilia 1998; 4: 654-60.